3-Methyl-4,5-methylenedioxyamphetamine
From Wikipedia, the free encyclopedia
|
3-Methyl-4,5-methylenedioxyamphetamine
|
|
| Systematic (IUPAC) name | |
| 1-(7-methyl-1,3-benzodioxol-5-yl)propan-2-amine | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C11H15NO2 |
| Mol. mass | 193.242 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
3-Methyl-4,5-methylenedioxyamphetamine or 5-Methyl-MDA is a ring-methylated derivative of the empathogenic drug MDA and a structural isomer of MDMA. It substitutes for MDA in animal tests and in vivo testing showed that 5-methyl-MDA is both several times more potent and much more selective as a releaser of serotonin over the other monoamines dopamine and noradrenaline compared to MDA itself. The other isomer 2-methyl-MDA is also more potent than MDA, although less potent than 5-methyl-MDA,[1] but both 6-methyl-MDA and the 6-methyl derivative of MDMA, Madam-6, are inactive, most likely due to steric hindrance.[2] Anecdotal reports from human users suggest that 5-methyl-MDA produces MDMA-like effects but is several times more potent by weight.
[edit] References
- ^ Parker MA, Marona-Lewicka D, Kurrasch D, Shulgin AT, Nichols DE. Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA). Journal of Medicinal Chemistry. 1998 Mar 12;41(6):1001-5. PMID 9526575
- ^ PIHKAL #98
|
|||||

